EP. 2: Patient Centered Approach: Important Patient Counseling Points regarding ctDNA results in CRC
January 3rd 2025Panelists discuss important patient counseling points regarding ctDNA results in colorectal cancer (CRC), focusing on how to communicate the implications of these results for treatment decisions, prognosis, and personalized care planning.
EP. 3: Expert Perspectives: GALAXY Results from CIRUCLATE study - Is it Practice Changing?
January 14th 2025Panelists discuss how the CIRCULATE study's GALAXY results demonstrate the potential impact of circulating tumor DNA analysis in guiding adjuvant therapy decisions for stage II colon cancer patients, though further validation is needed before widespread clinical implementation.
EP. 6: Exploring the NICHE-2 Trial: Neoadjuvant Immunotherapy in dMMR Colon Cancer
February 4th 2025Panelists discuss how the NICHE-2 trial results demonstrate the potential benefits and implementation of neoadjuvant immunotherapy in patients with dMMR colon cancer, highlighting pathologic response rates and implications for treatment sequencing.
EP. 7: Final Insights: Emerging role of MRD and ctDNA testing in Colon Cancer
February 11th 2025Panelists discuss how Minimal Residual Disease (MRD) and circulating tumor DNA (ctDNA) testing are revolutionizing colon cancer management through improved risk stratification, treatment selection, and surveillance strategies.